Loading clinical trials...
Loading clinical trials...
A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous Phase 2 And 3 EDP1815 Trials
Conditions
Interventions
EDP1815
Locations
54
United States
USA-131
Birmingham, Alabama, United States
USA 112
Fountain Valley, California, United States
USA 123
Fremont, California, United States
USA -101
Fort Lauderdale, Florida, United States
USA-124
Jacksonville, Florida, United States
USA-108
Miami, Florida, United States
Start Date
June 6, 2022
Primary Completion Date
May 25, 2023
Completion Date
June 7, 2023
Last Updated
September 7, 2023
NCT07217015
NCT06116526
NCT06461897
NCT07262983
NCT06389136
NCT06342713
Lead Sponsor
Evelo Biosciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions